Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Elekta AB is a Swedish company specializing in the development and production of medical technologies used in radiotherapy and radiosurgery for treating cancer and brain disorders. Founded in 1972 and headquartered in Stockholm, Sweden, Elekta offers a range of products including linear accelerators, brachytherapy solutions, and software for treatment planning and digital health records management. The company is recognized for its emphasis on precision and efficiency in treatment delivery. Elekta operates globally, serving hospitals and cancer care centers across multiple continents, leveraging technological innovations to improve patient outcomes and workflow efficiency in healthcare facilities. Its strategic focus includes the continuous advancement of image-guided radiation therapy technologies.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Elekta ABJohnson & Johnson
Last price
kr 59.45$273.20
Currency
SEK
USD
kr 24B$658B
-41.49
-kr 0.95$6.58
0.970.21
kr 2.40$5.28
4.04%1.96%
Sector
HealthHealth
Employees
3,996138,200
Ticker
Skr EKTA B$JNJ
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrEKTA B or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.